Statins in hemorrhagic stroke

References

• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet344(8934), 1383–1389 (1994).
   PubMed Web of Science ®Google Scholar
• LaRosa JC, He Jiang, Vupputuri S. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials. JAMA282(24), 2340–2346 (1999).
   PubMed Web of Science ®Google Scholar
• Amarenco P, Bogousslavsky J, Callahan A et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med.355(6), 549–559 (2006).
   PubMed Web of Science ®Google Scholar
• Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis. Systematic review and up-to-date meta-analysis. Stroke35, 2902–2909 (2004).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Danielson E, Fonseca FAH et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med.359(21), 2195–2207 (2008).
   PubMed Web of Science ®Google Scholar
• Everett BM, Glynn RJ, MacFadyen JG, Ridker PM. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein. Circulation121, 143–150 (2010).
   PubMed Web of Science ®Google Scholar
• DeCaterina R, Scarano M, Marfisi RM et al. Cholesterol-lowering interventions and stroke. J. Am. Coll. Cardiol.55(3), 198–211 (2010).
   PubMed Web of Science ®Google Scholar
• Sadowitz B, Maier K, Gahtan V. Statin therapy – part 1: the pleiotropic effects of statins in cardiovascular disease. Vasc. Endovascular Surg.44(4), 241–251 (2010).
   PubMed Web of Science ®Google Scholar
• Zipp F, Waiczies S, Aktas O et al. Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol. Sci.28(7), 342–349 (2007).
   PubMed Web of Science ®Google Scholar
• Willey JZ, Mitchell S, Elkind V. 3-Hydroxy-3-methylglutary 1-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch. Neurol.67, 1062–1067 (2010).
   PubMedGoogle Scholar
• Biffi A, Devan WJ, Anderson CD et al. Statin treatment and functional outcome after ischemic stroke. Stroke42, 1314–1319 (2011).
   PubMed Web of Science ®Google Scholar
• McGuinness B, O’Hare J, Craig D. Statins for the treatment of dementia. Cochrane Datase Syst. Rev.8, CD007514 (2010).
   PubMed Web of Science ®Google Scholar
• Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin. Biochem.40, 575–584 (2007).
   PubMed Web of Science ®Google Scholar
• Endres M, Laufs U. Effects of statins on endothelium and signaling mechanisms. Stroke35, 2708–2711 (2004).
   PubMed Web of Science ®Google Scholar
• Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat. Med.6(12), 1399–1402 (2000).
   PubMed Web of Science ®Google Scholar
• Chen J, Zhany ZG, Li Y et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol.53, 743–751 (2003).
   PubMed Web of Science ®Google Scholar
• Jung KH, Chu K, Jeong SW et al. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recover, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke35, 1744–1749 (2004).
   PubMed Web of Science ®Google Scholar
• Chopp M, Zhang ZG, Jiang Q. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke38, 827–831 (2007).
   PubMed Web of Science ®Google Scholar
• Karki K, Knight RA, Han Y et al. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke40, 3384–3389 (2009).
   PubMed Web of Science ®Google Scholar
• Shepherd J, Blauw GJ, Murphy MB et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet360, 1623–1630 (2002).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Lynch JR, Parra A et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke33, 2950–2956 (2002).
   PubMed Web of Science ®Google Scholar
• Fleming I, Busse R. Endothelial dysfunction: a novel therapeutic target. NO: the primary EDRF. J. Mol. Cell. Cardiol.31, 5–14 (1999).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Blessing R, Alexander MJ et al. Risk of cerebral vasospasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience. J. Neurosurg.105, 671–674 (2006).
   PubMed Web of Science ®Google Scholar
• Lynch JR, Wang H, McGirt MJ et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage. Results of a pilot randomized clinical trial. Stroke36, 2024–2026 (2005).
   PubMed Web of Science ®Google Scholar
• Chou SHY, Smith EE, Badjatia N et al. A randomized, double-blind placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke39, 2891–2893 (2008).
   PubMed Web of Science ®Google Scholar
• Tseng MY, Hutchinson PJ, Czosnyka M. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke38, 1545–1550 (2007).
   PubMed Web of Science ®Google Scholar
• Rinkel GJE, Klijn CJM. Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage. Pract. Neurol.9, 195–209 (2009).
   PubMedGoogle Scholar
• Sillberg VAH, Wells GA, Perry JJ. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage. A meta-analysis. Stroke39, 2622–2626 (2008).
   PubMed Web of Science ®Google Scholar
• Kramer AH. Statins in the management of aneurysmal subarachnoid hemorrhage – not (yet) a standard of care. Letters to the editor. Stroke40, e80–e81 (2009).
   Google Scholar
• Cook AM, Hessel EA. Meta-analysis of statins for aneurysmal subarachnoid hemorrhage falls short. Stroke40, e79 (2009).
   Google Scholar
• Vergouwen MDI, Meijers JCM, Geskus RB et al. Biologic effects of simvastatin in patients with aneurismal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J. Cereb. Blood Flow Metab.29, 1444–1453 (2009).
   PubMed Web of Science ®Google Scholar
• Vergouwen MDI, de Haan RJ, Vermeulen M et al. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage. A systematic review and meta-analysis update. Stroke41, e47–e52 (2010).
   PubMed Web of Science ®Google Scholar
• Kramer AH, Fletcher JJ. Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit. Care12, 285–296 (2010).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Ambrossi GLG, Huang J, Tamargo RJ. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study. J. Neurosurg.110, 268–274 (2009).
   Google Scholar
• Singhal AB, Topcuoglu MA, Dorer DJ et al. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology64, 1008–1013 (2005).
   PubMed Web of Science ®Google Scholar
• Risselada R, Straatman H, van Kooten F et al. Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke40, 2887–2892 (2009).
   PubMed Web of Science ®Google Scholar
• Moskowitz SI, Ahrens C, Provencio JJ et al. Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg. Neurol.71, 311–318 (2009).
   PubMedGoogle Scholar
• Laufs U, Endres M, Custodis F et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription. Circulation102, 3104–3110 (2000).
   PubMed Web of Science ®Google Scholar
• Puccetti L, Pasqui AL, Pastorelli M et al. Platelet hyperactivity after statin treatment discontinuation. Thromb. Haemost.90, 476–482 (2003).
   PubMed Web of Science ®Google Scholar
• Morgenstern LB, Hemphill JC, Anderson C et al. Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke41, 2108–2129 (2010).
   PubMed Web of Science ®Google Scholar
• Shimamoto T, Komachi Y, Inada H et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation79, 503–515 (1989).
   PubMed Web of Science ®Google Scholar
• Iso H, Jacobs DR, Wentworth D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N. Engl. J. Med.320(14), 904–910 (1989).
   PubMed Web of Science ®Google Scholar
• Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu heart program. Stroke20, 1460–1465 (1989).
   PubMed Web of Science ®Google Scholar
• Leppala JM, Virtamo J, Fogelholm R et al. Different risk factors for different stroke subtypes. Association of blood pressure, sholesterol, and antioxidants. Stroke30, 2535–2540 (1999).
   PubMed Web of Science ®Google Scholar
• Woo D, Kissela BM, Khoury JC et al. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage. A case–control study. Stroke35, 1360–1364 (2004).
   PubMed Web of Science ®Google Scholar
• Noda H, Iso H, Irie F et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage. Circulation119, 2136–2145 (2009).
   PubMed Web of Science ®Google Scholar
• Ebrahim S, Sung J, Song YM et al. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ333(7557), 22 (2006).
   PubMed Web of Science ®Google Scholar
• Goldstein LB, Amarenco P, Szarek M et al. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology70, 2364–2370 (2008).
   PubMed Web of Science ®Google Scholar
• Collins R, Armitage J, Parish S et al. Effects of the cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet363, 757–767 (2004).
   PubMed Web of Science ®Google Scholar
• Vergouwen MDI, de Haan RJ, Vermeulen M et al. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke39, 497–502 (2008).
   PubMed Web of Science ®Google Scholar
• Westover MB, Bianchi MT, Eckman MH et al. Statin use following intracerebral hemorrhage. Arch. Neurol.68, 573–579 (2011).
   PubMedGoogle Scholar
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet366, 1267–1278 (2005).
   PubMed Web of Science ®Google Scholar
• O’Regan C, Wu P, Arora P et al. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am. J. Med.121, 24–33 (2008).
   PubMed Web of Science ®Google Scholar
• Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol.8, 453–463 (2009).
   PubMed Web of Science ®Google Scholar
• Karki K, Knight RA, Han Y et al. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke40, 3384–3389 (2009).
   PubMed Web of Science ®Google Scholar
• Biffi A, Devan WJ, Anderson CD et al. Statin use and outcome after intracerebral hemorrhage. Case control study and meta-analysis. Neurology76, 1581–1588 (2011).
   PubMed Web of Science ®Google Scholar
• Fitz Maurice E, Wendell L, Snider R et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke39, 2151–2154 (2008).
   PubMed Web of Science ®Google Scholar
• Ricard G, Garant MP, Carrier N et al. Statins may increase intracerebral hemorrhage volume. Can. J. Neurol. Sci.37, 791–796 (2010).
   PubMed Web of Science ®Google Scholar
• Eichel R, Khoury ST, Ben-Hur T et al. Prior use of statins and outcome in patients with intracerebral haemorrhage. Eur. J. Neurology17, 78–83 (2010).
   PubMedGoogle Scholar
• Meier N, Nedeltchev K, Brekenfeld C et al. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemics. Stroke40, 1729–1737 (2009).
   PubMed Web of Science ®Google Scholar
• Bang OY, Saver JL, Liebeskind DS et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology68, 737–742 (2007).
   PubMed Web of Science ®Google Scholar
• Uyttenboogaart M, Koch MW, Koopman K et al. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J. Neurol.255, 875–880 (2008).
   PubMed Web of Science ®Google Scholar
• Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG et al. Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study. Cen. Eur. Neurosurg.70(1), 15–20 (2009).
   PubMedGoogle Scholar
• Naval NS, Abdelhak TA, Urrunaga N et al. An association of prior statin use with decreased perihematomal edema. Neurocrit. Care8, 13–18 (2008).
   PubMed Web of Science ®Google Scholar
• Westphal S, Albletshauser C, Luley C. Fluvastatin treatment and withdrawal: effects on endothelial function. Angiology59(5), 613–618 (2008).
   PubMed Web of Science ®Google Scholar
• Rosengarten B, Auch D, Kaps M. Effects of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans. Stroke38, 3193–3197 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas M, Mann J. Increased thrombotic vascular events after change of statin. Lancet352, 1830–1831 (1998).
   PubMed Web of Science ®Google Scholar
• Heeschen C, Hamm CW, Laufs U et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation105, 1446–1452 (2002).
   PubMed Web of Science ®Google Scholar
• Blanco M, Nombela F, Castellanos M et al. Statin treatment withdrawal in ischemic stroke. A controlled randomized study. Neurology69, 904–910 (2007).
   PubMed Web of Science ®Google Scholar
• Colivicchi F, Bassi A, Santini M, Caltagirone C. Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke38, 2652–2657 (2007).
   PubMed Web of Science ®Google Scholar
• LeManach Y, Godet G, Coriat P et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth. Analg.104, 1326–1333 (2007).
   PubMed Web of Science ®Google Scholar
• Kruger P, Fitzsimmons K, Cook D et al. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med.32(1), 11–14 (2006).
   PubMed Web of Science ®Google Scholar
• Kruger PS, Harward ML, Jones MA et al. Continuation of statin therapy in patients with presumed infection. A randomized controlled trial. Am. J. Respir. Crit. Care Med.183, 774–781 (2011).
   PubMedGoogle Scholar
• Smith EE, Nandigam KRN, Chen YW et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke41, 1933–1938 (2010).
   PubMed Web of Science ®Google Scholar
• Reed DM. The paradox of high risk of stroke in population with low risk of coronary heart disease. Am. J. Epidemiol.131(4), 679–688 (1990).
   Google Scholar
• Zia E, Hedblad B, Pessah-Rasmussen H et al. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke38, 2681–2685 (2007).
   PubMed Web of Science ®Google Scholar
• Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N. Engl. J. Med.333(21), 1392–1400 (1995).
   PubMed Web of Science ®Google Scholar
• Ariesen MJ, Claus SP, Rinkel GJE et al. Risk factors for intracerebral hemorrhage in the general population. A systematic review. Stroke34, 2060–2066 (2003).
   PubMed Web of Science ®Google Scholar
• Smith EE. Leukoaraiosis and stroke. Stroke41(Suppl. 1), S139–S143 (2010).
   PubMed Web of Science ®Google Scholar